Variant report
Variant | nsv527336 |
---|---|
Chromosome Location | chr8:115863500-115866116 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs10093354 | chr8:115863500-115863501 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
2 | rs367779396 | chr8:115863503-115863504 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
3 | rs72674430 | chr8:115863518-115863519 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
4 | rs546816324 | chr8:115863580-115863581 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
5 | rs115068510 | chr8:115863597-115863598 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
6 | rs558040903 | chr8:115863649-115863650 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs535925083 | chr8:115863651-115863652 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs77518314 | chr8:115863673-115863674 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs13266337 | chr8:115863705-115863706 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs146274422 | chr8:115863730-115863731 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs140010228 | chr8:115863732-115863733 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs191778038 | chr8:115863827-115863828 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs558708636 | chr8:115863849-115863850 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs541005046 | chr8:115863875-115863876 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs552677663 | chr8:115863906-115863907 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs572317073 | chr8:115863936-115863937 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs79754528 | chr8:115863943-115863944 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs541486452 | chr8:115863971-115863972 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs182896918 | chr8:115864017-115864018 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs143608883 | chr8:115864029-115864030 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs146810875 | chr8:115864078-115864079 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs573808641 | chr8:115864083-115864084 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs139320990 | chr8:115864121-115864122 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs528507266 | chr8:115864136-115864137 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs150034800 | chr8:115864140-115864141 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs377055501 | chr8:115864217-115864218 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs529416398 | chr8:115864235-115864236 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs13439575 | chr8:115864309-115864310 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
29 | rs186861968 | chr8:115864354-115864355 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs540013451 | chr8:115864452-115864453 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs76953335 | chr8:115864486-115864487 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs531140390 | chr8:115864516-115864517 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs544435057 | chr8:115864532-115864533 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs191771226 | chr8:115864544-115864545 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs72674432 | chr8:115864545-115864546 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
36 | rs552562499 | chr8:115864579-115864580 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs574053115 | chr8:115864602-115864603 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs182125852 | chr8:115864630-115864631 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs557405464 | chr8:115864741-115864742 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs74716906 | chr8:115864745-115864746 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs187710873 | chr8:115864762-115864763 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs145374201 | chr8:115864763-115864764 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs79352241 | chr8:115864788-115864789 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs573108096 | chr8:115864823-115864824 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
45 | rs77256440 | chr8:115864848-115864849 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
46 | rs149193296 | chr8:115864908-115864909 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
47 | rs562067452 | chr8:115864912-115864913 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
48 | rs113953159 | chr8:115864936-115864937 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
49 | rs529302559 | chr8:115864960-115864961 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
50 | rs551134073 | chr8:115864974-115864975 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Melanoma | 18172304 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Autism | 19415332 | CNVD |
Malaria | 21533027 | CNVD |
Non-syndromic sensorineural hearing loss | 22037309 | CNVD |
Esophageal cancer | 21851588 | CNVD |
Gastric cancer | 17908304 | CNVD |
Acute promyelocytic leukemia | 19109227 | CNVD |
Breast cancer | 21245420 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Liver carcinoma | 19366792 | CNVD |
Seminomas | 18059402 | CNVD |
Acute lymphoblastic leukemia | 21390130 | CNVD |
Pancreatic cancer | 21811587 | CNVD |
Thyroid cancer | 19087340 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Breast cancer | 17603634 | CNVD |
Testicular cancer | 18059402 | CNVD |
Breast cancer | 17133270 | CNVD |
Breast cancer | 21509527 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Breast cancer | 21858162 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Acute lymphoblastic leukemia | 21248843 | CNVD |
abnormal development | 18461090 | CNVD |
Oral cancer | 21386901 | CNVD |
Uveal melanoma | 21693616 | CNVD |
Langer-Giedion syndrome | 22283845 | CNVD |
Cancer | 21637783 | CNVD |
Splenic marginal zone lymphoma | 21957467 | CNVD |
Breast cancer | 20632083 | CNVD |
Breast cancer | 19602461 | CNVD |
Cancer | 22429812 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Oral cancer | 19627613 | CNVD |
Prostate cancer | 21088497 | CNVD |
colon cancer | 17210682 | CNVD |
Breast cancer | 21264507 | CNVD |
Breast cancer | 22028636 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Cancer | 16751803 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
Gastric cancer | 17167181 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Breast cancer | 16461572 | CNVD |
Human rectal carcinomas | 16397240 | CNVD |
Medulloblastoma | 16968546 | CNVD |
head and neck squamous cell carcinoma | 18028549 | CNVD |
Breast cancer | 17001317 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Lung cancer | 18438408 | CNVD |
Breast cancer | 16608533 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Hepatocellular carcinoma | 18803288 | CNVD |
Prostate cancer | 18632612 | CNVD |
Ovarian cancer | 22174824 | CNVD |
Prostate cancer | 16573809 | CNVD |
Malignant peripheral nerve sheath tumor | 18522746 | CNVD |
Carcinoma ex pleomorphic adenoma | 18828159 | CNVD |
Adenocarcinoma | 21044232 | CNVD |
Squamous cell cancer | 20885788 | CNVD |
T-cell prolymphocytic leukemia | 17713554 | CNVD |
Prostate cancer | 16461572 | CNVD |
Breast cancer | 21399628 | CNVD |
High-grade prostatic intraepithelial neoplasia | 16573809 | CNVD |
Acute lymphoblastic leukemia | 17690704 | CNVD |
Breast cancer | 17393978 | CNVD |
Burkitt''s lymphoma | 18698080 | CNVD |
Non-syndromic sensorineural hearing loss | 20606397 | CNVD |
Breast cancer | 17899364 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Colorectal cancer | 16774939 | CNVD |
Autosomal-dominant progressive external ophthalmoplegia | 19664747 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Congenital diaphragmatic hernia | 21085971 | CNVD |
Breast cancer | 21611746 | CNVD |
Developmental delay | 21147756 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Congenital diaphragmatic hernia | 21525063 | CNVD |
Non-small cell lung cancer | 19010865 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Chronic myeloid leukemia | 21384125 | CNVD |
Breast cancer | 21364760 | CNVD |
Neuroticism | 17667963 | CNVD |
Papillary thyroid cancer | 17515504 | CNVD |
Basal cell lymphoma | 17053054 | CNVD |
Bipolar disorder | 19114987 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr8:115862600-115863600 | Weak transcription | Adipose Derived Mesenchymal Stem Cell Cultured Cells | ES cell derived |
2 | chr8:115863600-115866000 | Enhancers | Adipose Derived Mesenchymal Stem Cell Cultured Cells | ES cell derived |
3 | chr8:115863800-115864400 | Enhancers | HSMMtube | muscle |
4 | chr8:115863800-115864600 | Enhancers | Mesenchymal Stem Cell Derived Adipocyte Cultured Cells | ES cell derived |
5 | chr8:115864400-115867800 | Weak transcription | HSMMtube | muscle |
6 | chr8:115864600-115868000 | Weak transcription | Mesenchymal Stem Cell Derived Adipocyte Cultured Cells | ES cell derived |
7 | chr8:115866000-115867800 | Weak transcription | Adipose Derived Mesenchymal Stem Cell Cultured Cells | ES cell derived |